Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
cold-like symptoms, including chills, coughing, sore throat, and nasal congestion; cold-like symptoms, including chills, coughing, sore throat, and nasal congestion; cold-like symptoms, including chills, coughing, sore throat, and nasal congestion; cold-like symptoms, including chills, coughing, sore throat, and nasal congestion; cold-like symptoms, including chills, coughing, sore throat, and nasal congestion; This is a spontaneous report received from a Consumer or other non HCP, Program ID: . A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), COUGH (non-serious), OROPHARYNGEAL PAIN (non-serious), NASAL CONGESTION (non-serious), CHILLS (non-serious), outcome "unknown" and all described as "cold-like symptoms, including chills, coughing, sore throat, and nasal congestion". No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.